Accueil   Diary - News   All news Seqens renews its partnership and collaboration with Arkema for the development of its Medical IMPEKK™ PEKK for long-term implants, ideal for use in 3D printing.

Seqens renews its partnership and collaboration with Arkema for the development of its Medical IMPEKK™ PEKK for long-term implants, ideal for use in 3D printing.

 

Seqens is pleased to announce the signing of a Letter of Intent to renew its partnership and collaboration with Arkema, a world leader in specialty materials, in the development of its IMPEKK™ Medical PEKK for long-lasting implants.

 

Since 2010, Arkema has licensed exclusively to the Seqens group (via its subsidiary Seqens CDMO, EX PCAS) its "PEKK" (Poly-Ether-Ketone-Ketone) production technology for the implantable medical market. Seqens produces PEKK at its production site in Couterne, France. PEKK is part of the "PAEK" ("Poly-Aryl-Ether-Ketone") family already widely used in the field of medical implants, through traditional means of implementation (injection, machining of semi-products).

 

Read the press release